The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors
2008 · Cancer Research · 163 citations
https://doi.org/10.1158/0008-5472.can-08-0835
J
Joan M. Carboni
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
190
Papers
5.5K
Citations
40
h-index
69
i10-index
Joan M. Carboni is an academic researcher from Bristol-Myers Squibb (United States). The author has contributed to research in topics: Growth Hormone and Insulin-like Growth Factors & Metabolism, Diabetes, and Cancer & Cancer, Hypoxia, and Metabolism. The author has an h-index of 40, co-authored 162 publications.
Papers by this author
worksHigh IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti–IGF-IR Therapy
2010 · Clinical Cancer Research · 129 citations
https://doi.org/10.1158/1078-0432.ccr-10-1903
HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924
2008 · Molecular Cancer Therapeutics · 101 citations
https://doi.org/10.1158/1535-7163.mct-08-0493
Use of a Photoactivatable Taxol Analogue to Identify Unique Cellular Targets in Murine Macrophages: Identification of Murine CD18 as a Major Taxol-Binding Protein and a Role for Mac-1 in Taxol-Induced Gene Expression
1999 · The Journal of Immunology · 67 citations
https://doi.org/10.4049/jimmunol.162.12.7335
Paclitaxel, a Mimetic of Bacterial Lipopolysaccharide (LPS) in Murine Macrophages
1994 · ACS symposium series · 6 citations
https://doi.org/10.1021/bk-1995-0583.ch012
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat